Walgreens Boots Alliance Inc (NASDAQ:WBA) Stake Lessened by Princeton Portfolio Strategies Group LLC

Princeton Portfolio Strategies Group LLC reduced its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 14.6% in the third quarter, according to its most recent filing with the SEC. The fund owned 59,994 shares of the pharmacy operator’s stock after selling 10,292 shares during the period. Walgreens Boots Alliance comprises 1.1% of Princeton Portfolio Strategies Group LLC’s portfolio, making the stock its 29th biggest position. Princeton Portfolio Strategies Group LLC’s holdings in Walgreens Boots Alliance were worth $4,374,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of WBA. Asset Dedication LLC lifted its holdings in shares of Walgreens Boots Alliance by 204.6% in the 3rd quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after buying an additional 1,060 shares during the period. BlueMountain Capital Management LLC acquired a new position in Walgreens Boots Alliance in the 2nd quarter worth about $103,000. CSat Investment Advisory L.P. acquired a new position in Walgreens Boots Alliance in the 2nd quarter worth about $104,000. Squar Milner Financial Services LLC acquired a new position in Walgreens Boots Alliance in the 2nd quarter worth about $106,000. Finally, Kaizen Advisory LLC raised its holdings in Walgreens Boots Alliance by 128.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock worth $116,000 after purchasing an additional 1,083 shares during the period. 62.59% of the stock is owned by hedge funds and other institutional investors.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $79.48, for a total value of $217,457.28. Following the completion of the sale, the director now directly owns 8,207 shares of the company’s stock, valued at approximately $652,292.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Kathleen Wilson-Thompson sold 52,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Wednesday, October 31st. The stock was sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the completion of the sale, the executive vice president now directly owns 81,076 shares of the company’s stock, valued at $6,386,356.52. The disclosure for this sale can be found here. Over the last three months, insiders have sold 73,756 shares of company stock valued at $5,824,194. Corporate insiders own 14.80% of the company’s stock.

A number of research firms recently weighed in on WBA. Zacks Investment Research cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Monday. Morgan Stanley set a $77.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a research note on Monday. BidaskClub upgraded Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Friday, September 28th. Barclays upped their price target on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research report on Friday, October 12th. Finally, ValuEngine upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Friday, October 12th. One analyst has rated the stock with a sell rating, thirteen have assigned a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $78.84.

NASDAQ:WBA traded up $1.02 during trading hours on Monday, hitting $85.69. The company’s stock had a trading volume of 6,187,512 shares, compared to its average volume of 6,251,767. The firm has a market capitalization of $80.37 billion, a PE ratio of 14.23, a price-to-earnings-growth ratio of 1.32 and a beta of 0.76. The company has a debt-to-equity ratio of 0.47, a current ratio of 0.82 and a quick ratio of 0.38. Walgreens Boots Alliance Inc has a 52-week low of $59.07 and a 52-week high of $85.83.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, October 11th. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.45 by $0.03. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. The company had revenue of $33.44 billion for the quarter, compared to analyst estimates of $33.64 billion. As a group, equities analysts anticipate that Walgreens Boots Alliance Inc will post 6.54 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Monday, November 12th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.05%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 29.24%.

COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance Inc (NASDAQ:WBA) Stake Lessened by Princeton Portfolio Strategies Group LLC” was originally published by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this story on another publication, it was illegally copied and republished in violation of US & international trademark & copyright law. The original version of this story can be read at https://www.baseballdailydigest.com/news/2018/12/03/princeton-portfolio-strategies-group-llc-sells-10292-shares-of-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: What is a Market Correction?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply